Fermé, Christophe <br/><br/>
Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2002 
 - 467-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2002.20.2.467  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carmustine--administration & dosage<br/>Cytarabine--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm<br/>Etoposide--administration & dosage<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Mitoguazone--administration & dosage<br/>Recurrence<br/>Salvage Therapy<br/>Transplantation, Autologous<br/>Vinblastine--administration & dosage<br/>Vinorelbine